- Report
- March 2025
- 200 Pages
Global
From €3999EUR$4,490USD£3,459GBP
- Report
- February 2025
- 200 Pages
Global
From €3999EUR$4,490USD£3,459GBP
- Report
- June 2025
- 185 Pages
Global
From €4008EUR$4,500USD£3,467GBP
- Report
- August 2024
- 170 Pages
Global
From €4008EUR$4,500USD£3,467GBP
- Report
- August 2025
- 285 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 290 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 363 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 284 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 281 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 274 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 182 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 177 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 190 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 370 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 381 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 263 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 474 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 492 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 269 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 372 Pages
Global
From €5210EUR$5,850USD£4,507GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more